Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

The AI-Mayo PE (AIM PE) Study: Validation of an Artificial Intelligence Algorithm Using Electrocardiograms to Predict Pulmonary Emboli

Damon E. Houghton, Kan Liu, Francisco Lopez-Jimenez, Ryan Meverden, Robert D. McBane, Stan Henkin, Ana I. Casanegra, Waldemar Wysokinski

Blood (2024) 144 (Supplement 1): 811.

https://doi.org/10.1182/blood-2024-199160

Published: 2024

Journal Articles

Pulmonary Embolism and the Impact of Concomitant Deep Vein Thrombosis on Outcomes Among Cancer Patients

Steven Callori, Robert D. McBane, Danielle T. Vlazny, Damon E. Houghton, David Froehling, David O. Hodge, Ana I. Casanegra, Waldemar E. Wysokinski

Blood (2023) 142 (Supplement 1): 2641.

https://doi.org/10.1182/blood-2023-187012

Published: 2023

Journal Articles

Extended Full Dose Versus Low Dose Direct Oral Anticoagulants in Cancer and Overweight Patients

Danielle T. Vlazny, Azza Ahmed, David O. Hodge, Teresa Lang, Waldemar E. Wysokinski, Ana I. Casanegra, Lisa Peterson, Robert D. McBane, Damon E. Houghton

Blood (2023) 142 (Supplement 1): 1276.

https://doi.org/10.1182/blood-2023-180168

Published: 2023

Journal Articles

Venous Thromboembolism Outcomes Among Cancer and Non-Cancer Patients Managed with Patient-Centric Guideline-Driven Protocol

Claire E. Cassianni, Robert D. McBane, Danielle T. Vlazny, David O. Hodge, Ana I. Casanegra, Damon E. Houghton, Waldemar E. Wysokinski

Blood (2023) 142 (Supplement 1): 1269.

https://doi.org/10.1182/blood-2023-180786

Published: 2023

Journal Articles

Accuracy and Prediction of D-Dimers for Pulmonary Embolism in Patients with COVID-19 Infection

Damon E. Houghton, Ewa Wysokinska, Ana I. Casanegra, Leslie Padrnos, Surbhi Shah, Waldemar E. Wysokinski, Rajiv K. Pruthi, Heather A Heaton, Robert D. McBane

Blood (2022) 140 (Supplement 1): 5647–5648.

https://doi.org/10.1182/blood-2022-156448

Published: 2022

Journal Articles

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations

Damon E. Houghton, David M Scott, Waldemar E. Wysokinski, Rajiv K. Pruthi, Meera Sridharan, Leslie Padrnos, Surbhi Shah, Aneel A. Ashrani, Anand Padmanabhan, Ewa Wysokinska, Robert D. McBane, Lisa Baumann Kreuziger

Blood (2022) 140 (Supplement 1): 8545–8547.

https://doi.org/10.1182/blood-2022-168142

Published: 2022

Journal Articles

Outcomes of Patients with Extended Anticoagulation Using Low Dose Doacs Compared to Standard Therapeutic Anticoagulation

Azza Ahmed, Ahmed Pasha, David O. Hodge, Ana I Casanegra, Lisa Peterson, Danielle Vlazny, Robert D. McBane, Waldemar Wysokinski, Damon E. Houghton

Blood (2021) 138 (Supplement 1): 1960.

https://doi.org/10.1182/blood-2021-154088

Published: 2021

Journal Articles

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy

Adrienne Kaufman, Yael Kusne, Molly Klanderman, Heidi E. Kosiorek, Thomas Oliver, Miguel Gonzalez-Velez, Robert D. McBane, Waldemar E. Wysokinski, Damon E. Houghton, Leslie Padrnos

Blood (2021) 138 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2021-154453

Published: 2021

Journal Articles

Association between Cancer and Anatomical Site of Venous Thromboembolic Disease

David A Froehling, MD, Damon E. Houghton, MDMS, Waldemar E. Wysokinski, MD PhD, Robert D. McBane, MD, Danielle Vlazny, PA-C, David Hodge, Lisa Peterson, RN, Ana I Casanegra, MD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-141463

Published: 2020

Journal Articles

Reduced Calf Muscle Pump Function Is a Risk Factor for Venous Thromboembolism and Mortality

Damon E. Houghton, MDMS, Aneel A. Ashrani, MD MS, Ramila Mehta, MS, David O. Hodge, MS, David Liedl, RN, Thom Rooke, MD, Paul E. Wennberg, MD, Robert D. McBane, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-139385

Published: 2020

Journal Articles

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Frits I. Mulder, Floris T. M. Bosch, Annie M. Young, Andrea Marshall, Robert D. McBane, II, Tyler J. Zemla, Marc Carrier, Pieter Willem Kamphuisen, Patrick M. M. Bossuyt, Harry R. Büller, Jeffrey I. Weitz, Saskia Middeldorp, Nick van Es

Blood (2020) 136 (12): 1433–1441.

https://doi.org/10.1182/blood.2020005819

Published: 2020

Includes: Supplemental data

Journal Articles

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

Damon E. Houghton, MDMS, Jordan Cochuyt, David O. Hodge, MS, Danielle Vlazny, PA-C, Ana I Casanegra, MD, Lisa Peterson, RN, David A Froehling, MD, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD

Blood (2019) 134 (Supplement_1): 2158.

https://doi.org/10.1182/blood-2019-125099

Published: 2019

Journal Articles

Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database

Ewa Wysokinska, MD, Damon E. Houghton, MDMS, Danielle Vlazny, PA-C, Aneel A. Ashrani, MD MS, David A Froehling, MD, David O. Hodge, MS, Lisa Peterson, RN, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, Ana I Casanegra, MD

Blood (2019) 134 (Supplement_1): 1147.

https://doi.org/10.1182/blood-2019-131547

Published: 2019

Journal Articles

Efficacy and Safety of Prothrombin Complex Concentrate (PCC) for Direct Oral Anticoagulant Reversal: A Single Institutional Experience

Meera Sridharan, MD, Narith N Ou, Pharm.D., R.Ph, Lance J. Oyen, Pharm.D., R.Ph, Aneel A. Ashrani, MD, M.S., Robert D. McBane, MD, Rajiv K. Pruthi, M.B.B.S.

Blood (2018) 132 (Supplement 1): 2533.

https://doi.org/10.1182/blood-2018-99-112227

Published: 2018

Journal Articles

Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin

Damon E. Houghton, MD, Dalene M. Bott-Kitslaar, APRN, CNP, Emily Vargas, MPH, David O. Hodge, MS, Teresa R Lang, PA-C, Lisa Peterson, RN, Ana I Casanegra, MD, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, David A Froehling, MD

Blood (2018) 132 (Supplement 1): 362.

https://doi.org/10.1182/blood-2018-99-114185

Published: 2018

Journal Articles

Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial

Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, Jennifer Le-Rademacher, PhD, Aneel A. Ashrani, MD, M.S., Alfonso J Tafur, MD MS, RPVI, FSVM, Krishna Gundabolu, MBBS, Juliana Perez-Botero, MD, Usha Perepu, MD, Daniel M. Anderson, MD MPH, Charles Kuzma, MD, Roberto leon Ferre, MD, Stanislav Henkin, MD, Charles Lenz, MD, Charles Loprinzi, MD

Blood (2018) 132 (Supplement 1): 421.

https://doi.org/10.1182/blood-2018-99-118808

Published: 2018

Journal Articles

Direct Oral Anticoagulants in Patients with Myeloproliferative Neoplasms: A Single Institution Retrospective Study

Emma P. Deloughery, BS, Robert D. McBane, MD, Aneel A. Ashrani, MD, M.S., Ayalew Tefferi, MD, Joshua P Slusser, Rajiv K. Pruthi, M.B.B.S.

Blood (2018) 132 (Supplement 1): 5067.

https://doi.org/10.1182/blood-2018-99-114234

Published: 2018

Journal Articles

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Blood (2018) 132 (Supplement 1): LBA-1.

https://doi.org/10.1182/blood-2018-120738

Published: 2018

Journal Articles

Inpatient Outcomes and Rates of Venous Thromboembolism and Gastrointestinal Hemorrhage in Patients with Gastric Cancer: Results from Nationwide Inpatient Sample Database 2009-2014

Harry E Fuentes-Bayne, MD, Urshila Durani, MD, Robert D. McBane, MD, Rajiv K. Pruthi, M.B.B.S., Aneel A. Ashrani, MD, M.S., Ariela L. Marshall, MD

Blood (2018) 132 (Supplement 1): 5882.

https://doi.org/10.1182/blood-2018-99-120128

Published: 2018

Journal Articles

Safety and Efficacy of Apixaban and Rivaroxaban for the Treatment of Upper Extremity Deep Vein Thrombosis

Damon E. Houghton, MD MSc, Dalene M. Bott-Kitslaar, APRN, CNP, Emily Vargas, MPH, David O. Hodge, MS, Teresa R. Ransone, PA-C, Ana Casanegra, MD, Lisa Peterson, RN, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD

Blood (2017) 130 (Supplement 1): 2137.

https://doi.org/10.1182/blood.V130.Suppl_1.2137.2137

Published: 2017

NARROW

The AI-Mayo PE (AIM PE) Study: Validation of an Artificial Intelligence Algorithm Using Electrocardiograms to Predict Pulmonary Emboli

Pulmonary Embolism and the Impact of Concomitant Deep Vein Thrombosis on Outcomes Among Cancer Patients

Extended Full Dose Versus Low Dose Direct Oral Anticoagulants in Cancer and Overweight Patients

Venous Thromboembolism Outcomes Among Cancer and Non-Cancer Patients Managed with Patient-Centric Guideline-Driven Protocol

Accuracy and Prediction of D-Dimers for Pulmonary Embolism in Patients with COVID-19 Infection

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations

Outcomes of Patients with Extended Anticoagulation Using Low Dose Doacs Compared to Standard Therapeutic Anticoagulation

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy

Association between Cancer and Anatomical Site of Venous Thromboembolic Disease

Reduced Calf Muscle Pump Function Is a Risk Factor for Venous Thromboembolism and Mortality

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database

Efficacy and Safety of Prothrombin Complex Concentrate (PCC) for Direct Oral Anticoagulant Reversal: A Single Institutional Experience

Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin

Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial

Direct Oral Anticoagulants in Patients with Myeloproliferative Neoplasms: A Single Institution Retrospective Study

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Inpatient Outcomes and Rates of Venous Thromboembolism and Gastrointestinal Hemorrhage in Patients with Gastric Cancer: Results from Nationwide Inpatient Sample Database 2009-2014

Safety and Efficacy of Apixaban and Rivaroxaban for the Treatment of Upper Extremity Deep Vein Thrombosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only